EBP50 (SLC9A3R1) Human shRNA Plasmid Kit (Locus ID 9368)
CAT#: TR316855
SLC9A3R1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 3 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | EBP50 (SLC9A3R1) Human shRNA Plasmid Kit (Locus ID 9368) |
Locus ID | 9368 |
UniProt ID | O14745 |
Synonyms | EBP50; NHERF; NHERF-1; NHERF1; NPHLOP2 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | SLC9A3R1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 9368). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_004252, NM_004252.1, NM_004252.2, NM_004252.3, NM_004252.4, BC003361, BC003361.1, BC001443, BC011777, BC049220, BC053350, NM_004252.5 |
Summary | This gene encodes a sodium/hydrogen exchanger regulatory cofactor. The protein interacts with and regulates various proteins including the cystic fibrosis transmembrane conductance regulator and G-protein coupled receptors such as the beta2-adrenergic receptor and the parathyroid hormone 1 receptor. The protein also interacts with proteins that function as linkers between integral membrane and cytoskeletal proteins. The protein localizes to actin-rich structures including membrane ruffles, microvilli, and filopodia. Mutations in this gene result in hypophosphatemic nephrolithiasis/osteoporosis type 2, and loss of heterozygosity of this gene is implicated in breast cancer.[provided by RefSeq, Sep 2009] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (3)
The use of this RNAi has been cited in the following citations: |
---|
NHERF1 Regulates Parathyroid Hormone Receptor Desensitization: Interference with ß-Arrestin Binding
,Bin Wang, Yanmei Yang, Abdul B. Abou-Samra, and Peter A. Friedman,
Mol. Pharmacol., May 2009; 75: 1189 - 1197.
[SLC9A3R1]
|
NHERF1 Regulates Parathyroid Hormone Receptor Desensitization; Interference with -arrestin Binding
,Bin Wang, Yanmei Yang, Abdul Abou-Samra, and Peter Friedman,
Mol. Pharmacol., Feb 2009; 10.1124/mol.108.054486.
[SLC9A3R1]
|
NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling
,Bin Wang, Alessandro Bisello, Yanmei Yang, Guillermo G Romero, and Peter A Friedman,
J Biol Chem. 2007 Dec 14;282(50):36214-22.
[SLC9A3R1]
|
Documents
Product Manuals |
FAQs |
SDS |
其它SLC9A3R1产品
Customer
Reviews
Loading...